Follow up of GCG Implementation Result in 2012
No Aspek Governance Governance Aspect Rekomendasi (AOI) Recommendation Kategori /Status Category/Status S P B
1. Komitmen Terhadap Penerapan Tata Kelola Perusahaan Yang Baik
Comitment towards Good Corporate Governance implementation 4 3 - 1
2. Pemegang Saham Dan Rups/Pemilik Modal | Shareholders and AGM/Equity Owners 5 1 3 1
3. Dewan Komisaris/Dewan Pengawas | BOC/Monitoring Committee 17 14 3
-4. Direksi | BOD 37 14 13 10
5. Pengungkapan Dan Keterbukaan Informasi
Disclosure and Information Transparency 3 1 - 2
6. Aspek / Faktor Lainnya | Other Aspect/Factor - - -
-Jumlah | Total 66 33 19 14
Catatan/ Note:
No Category/StatusKategori/status KeteranganAnnotation
1. S Selesai, sudah ada tindaklanjutnya dan selesai | Finished, followed up and completed
2. P Proses, sudah ditindaklanjuti sebagian,namun masih ada yang diproses | On process, partly followed up, partly on going 3. B Belum ada tindaklanjutnya | Not yet followed up
Atas capaian tersebut, kedepannya Komite GCG dan Pemantauan Risiko tetap berupaya untuk me-monitoring tindaklanjut rekomendasi (AOI) dengan kategori/status Proses (P) dan Belum (B) sampai dengan pelaksanaan assessment GCG 2015 dengan memperhatikan rencana kerja oleh pihak/aspek terkait. Hasil
monitoring ini digunakan sebagai dasar evaluasi lanjutan tahun berikutnya karena pada tahun 2015 direncanakan/diprogram akan dilaksanakan penilaian secara berkala setiap dua tahun oleh penilai (assessor) independen atau jasa instansi pemerintah yang ditunjuk oleh Dewan Komisaris.
Di samping itu, Komite GCG dan Pemantauan Risiko melakukan sosialisasi infrastruktur GCG melalui distribusi memo internal dari Bidang CPRM No. 32/CPRM/XII/2014 tanggal 1 Desember 2014, ke lingkungan internal Perseroan, yaitu Direksi, Dewan Komisaris beserta organ Dewan Komisaris dan seluruh Manajer, Asisten Manajer dan karyawan. Materi Infrastruktur GCG yang disosialisasikan yaitu :
a. Pedoman Tata Kelola Perusahaan (Code of Corporate Governance) yang disahkan tanggal 23 November 2012 oleh Direktur Utama dan Komisaris Utama.
Upon these achievements, GCG and Risk Monitoring Committee are attempting to monitor the recommendation follow up (AOI) with category/status of Process (P) and Undone (B) until the implementation of 2015 GCG assessment with regard to work plan and related aspects. The results of this monitoring are used as a basis for further evaluation of the following year in 2015, thanks to periodic assessments plan/program conducted in every two years by independent assessor or government institutions or service appointed by the Board of Commissioners.
In addition, GCG and Risk Monitoring Committee are socializing GCG infrastructure through an internal memo distribution of Division of CPRM No. 32/CPRM/XII/2014 on December 1, 2014, to the Company's internal environment, the Board of Directors, Board of Commissioners and its Organs, and the entire Managers, Assistant Managers, and employees. The material of socialized GCG infrastructure are:
a. Code of Corporate Governance, passed on November 23, 2012 by President Director and President Commissioner.
Laporan Tahunan 2014 PT Indofarma (Persero) Tbk - 156 - Mewujudkan Momentum Perubahan I Kinerja 20142014 Performance II Laporan ManajemenManagement Report III Profil PerusahaanCompany Profile
b. Pedoman Etika Usaha dan Etika Perilaku (Code of Conduct) yang disahkan tanggal 23 November 2012 oleh Direktur Utama dan Komisaris Utama.
c. Board Manual yang ditandatangani oleh Seluruh Anggota Direksi dan Anggota Dewan Komisaris tanggal 23 November 2012.
d. Charter Komite Audit yang disahkan tanggal 19 November 2012 oleh Ketua Komite Audit yang diketahui oleh Direktur Utama dan Komisaris Utama.
e. Charter Satuan Pengawasan Intern yang disahkan tanggal 19 November 2012 oleh Direktur Utama dan Komisaris Utama.
f. Kebijakan Sistem Pengendalian internal No. 075/DIR/SK/ II/2008 yang disahkan tanggal 4 Februari 2008. g. Kebijakan Pengendalian Gratifikasi No. 765/DIR/SK/
XI/2012 yang disahkan tanggal 22 November 2012. h. Kebijakan Laporan Harta Kekayaan Penyelenggara
Negara (LHKPN) No. 766/DIR/SK/XI/2012 yang disahkan tanggal 22 November 2012.
i. Rencana Kerja dan Anggaran Perusahaan (RKAP) Revisi 2014 yang disahkan oleh Dewan Komisaris
Kecuali RKAP 2014, Semua infrastruktur GCG tersebut telah diupload ke situs resmi Perseroan yaitu di www.indofarma.co.id/ investors/corporate governance.
Komite GCG dan Pemantauan Risiko juga melakukan sosialisasi tentang perubahan/revisi kebijakan Whistleblowing System
(WBS) kepada karyawan di Perseroan dilakukan melalui memo Sekretaris Perusahaan No. 455/CG/VI/14 tgl 16 Juni 2014 kepada seluruh manajer Perseroan dan Manajer anak usaha IGM, serta pemasangan banner di beberapa lokasi di Kantor Cibitung dan Kantor Manggarai. Materi WBS yang belum direvisi sudah dimuat di www.indofarma.co.id, namun SK No.670/DIR/SK/X/2012 tanggal 4 oktober 2012 tentang kebijakan WBS beserta lampirannya berupa Tata Kerja Pengelolaan serta SPI Charter
belum direvisi terkait perubahan penanggungjawab dari SPI kepada Sekretaris Perusahaan yang merupakan tanggungjawab Tim Revisi TKP WBS No. 0516/DIR/SK/V/2014 tanggal 28 Mei 2014. Namun sampai saat ini belum ada perubahan.
Komite GCG dan Pemantauan Risiko melaksanakan sosialisasi Pedoman Manajemen Risiko yang di dalamnya terdapat kebijakan manajemen risiko ke seluruh bidang/manajer di lingkungan
b. Code of Conduct, passed on November 23, 2012 by President Director and President Commissioner. c. Board Manual, signed by the entire BOD and BOC, on
November 23, 2012.
d. Audit Committee Charter passed on November 19, 2012, by the Chairman of Audit Committee, acknowledged by both President Director and President Commissioner. e. Internal Control Unit Charter passed on November 19,
2012 by President Director and President Commissioner. f. The policy of Internal Control System No. 075/DIR/SK/
II/2008 passed on February 4, 2008.
g. The policy of Gratification Control No. 765/DIR/SK/ XI/2012 passed on November 22, 2012.
h. The policy on Report on Material Wealth of State Figures (LHKPN) No. 766/DIR/SK/XI/2012 has been passed on November 22, 2012.
i. Revised 2014 Annual Work Plan and Budget passed by the BOC.
Except the 2014 Annual Work Plan and Budget, the aforementioned GCG infrastructure had been uploaded to the Company’s official website in www.indofarma.co.id/investors/ corporate governance.
GCG and Risk Monitoring Committee also conducted the socialization on changes/revisions of Whistleblowing System (WBS) policies to employees with the Memo of Corporate Secretary No. 455/CG/VI/14 on June 16, 2014 to all managers of the Company and the managers of its subsidiary IGM, and putting up banners at several locations in Cibitung and Manggarai offices. The unrevised WBS material have been uploaded in www.indofarma.co.id, but Decree No. 670/DIR/SK/X/2012 on October 4, 2012 on the WBS policy, along with attachments of Management Procedure and unrevised Internal Audit Charter in relation with authorization changes from Internal Audit to the Corporate Secretary, which is the responsibility of the Revision team WBS No. 0516/DIR/SK/V/2014 on May 28, 2014. However, there has been no revision to date.
GCG and Risk Monitoring Committee are conducting the socialization of Risk Management Guidelines which include risk management policy to the entire divisions/managers in
Organ Tata Kelola Perusahaan
Annual Report 2014 PT Indofarma (Persero) Tbk Actualizing the Momentum of Revitalization 157
-IV Analisis dan Pembahasan ManajemenManagement Discussion And Analysis V Tata Kelola PerusahaanCorporate Governance VI Menuju KeberlanjutanTowards Sustainability
Perseroan melalui memo internal dari Bidang CPRM No. 003/ RM-C/VII/2014 tanggal 14 JuIi 2014. Materi Pedoman Manajemen Risiko Perseroan telah diunggah di situs elektronik Perseroan. Komite GCG dan Pemantauan Risiko juga melaksanakan evaluasi (self assessment) penerapan GCG tahun buku 2013 oleh Bidang CPRM dari 5 November – 5 Desember 2014 dengan Laporan No. 035/CPRM/XII/2014 tanggal 12 Desember 2014 dan telah disampaikan kepada Ketua Komite GCG dan Pemantauan Risiko oleh Direktur Utama selaku Penanggung Jawab Penerapan GCG dengan No. 1961/DIR/XII/2014 tanggal 19 Desember 2014.
Lingkup pelaksanaan evaluasi meliputi dua sasaran, yaitu pelaksanaan tindaklanjut hasil rekomendasi penilaian (assessment) penerapan GCG tahun 2012 oleh BPKP perwakilan Proinsi Jawa Barat dan pelaksanaan evaluasi (self assessment) terhadap penerapan GCG oleh Perseroan di tahun buku 2013. Sehingga, evaluasi (self assessment) dilakukan sebatas data yang diperoleh Bidang CPRM selama proses evaluasi (self assessment) yaitu berupa evaluasi tindaklanjut usulan rekomendasi penerapan GCG oleh aspek terkait governance
dan evaluasi penerapan parameter/indikator GCG yang nilai Unsur Pemenuhannya (UP) dibawah nilai 1 (satu), berdasarkan Kertas Kerja Penilaian Penerapan GCG Perseroan tahun 2012 dari BPKP perwakilan Provinsi Jawa Barat.
Tentang hasil pelaksanaan evaluasi (self assessment) penerapan GCG tahun buku 2013 oleh Bidang CPRM dapat dilihat pada bagian Penilaian Tata Kelola Perusahaan pada bab ini.
Kebijakan Remunerasi
Perseroan memiliki kebijakan remunerasi kepada Komite GCG dan Pemantauan Risiko. Bagi Ketua Komite GCG dan Pemantauan Risiko/Komisaris, Rina Moreta, kebijakan remunerasi disesuaikan dengan remunerasi Dewan Komisaris. Kepada Anggota Komite GCG dan Pemantauan Risiko, Tarcicious Sawardi, Perseroan memberikan kebijakan remunerasi sebagai berikut,
the Company through an internal memo from the Division of CPRM No. 003/RM-C/VII/2014 on July 14, 2014. The content of such Guidelines has been uploaded on the Company’s website. GCG and Risk Monitoring Committee also conducted self-assessment evaluations of GCG implementation in the fiscal year of 2013 by Division of CPRM from November 5 to December 5, 2014, with the Report No. 035/CPRM/XII/2014 on December 12, 2014, and submitted to the Head of the GCG Committee and Risk Monitoring by the President Director as the person-in-charge for GCG implementation with the Decree No. 1961/ DIR/XII/2014 on December 19, 2014.
The scope of the evaluation includes two objectives, namely the assessment recommendation result follow-up on GCG implementation in 2012 by Development and Finance Controller (BPKP) representatives of West Java province, and self-assessment evaluation of the Company’s GCG implementation by the Company for 2013 fiscal year. The self-assessment evaluation is limited to data obtained by CPRM division during this self-assessment process, which is a follow-up evaluation of the proposed GCG implementation recommendation by the governance-related aspect, and evaluation of GCG parameters/ indicators implementation whose fulfillment element value are under 1 (one), based on the Working Paper Assessment of Company’s GCG implementation in 2012 from Development and Finance Controller (BPKP) representatives of West Java province. The results of the evaluation (self-assessment) on GCG implementation of 2013 fiscal year by Division of CPRM can be seen on the GCG Assessment in this chapter.
Remuneration Policy
The Company has remuneration policy to the GCG and Risk Monitoring Committee. For the Head of GCG and Risk Monitoring Committee/Commissioner, Rina Moreta, remuneration policies are adjusted to the remuneration of the Board of Commissioners. To Members of GCG and Risk Monitoring Committee, Tarcicious Sawardi, the Company provides the following remuneration policy,
Laporan Tahunan 2014 PT Indofarma (Persero) Tbk - 158 - Mewujudkan Momentum Perubahan I Kinerja 20142014 Performance II Laporan ManajemenManagement Report III Profil PerusahaanCompany Profile